Key result
The 28th Scientific Conference of the International Aspirin Foundation facilitated international discussion on aspirin's mechanisms of action and its utility in modern medicine.
This conference report summarizes international, multidisciplinary discussions on the current understanding and future research directions for aspirin.
Conference on aspirin's legacy sparks hypotheses; leaves open new cardiovascular research questions.
Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow's lecture hall at Charité, within Berlin's Museum of Medical History, the International Aspirin Foundation's 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin's mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health. In addition to the delegates in Berlin, 300 medical doctors at the 19th Annual Scientific Congress of the Chinese Society of Cardiology were able to join the cardiology sessions from Taiyuan, Shangxi province via a live streaming link to and from China. This led to useful discussion and allowed a truly international perspective to the meeting.
No takes yet. Share an insight, caveat, or question.
Walker et al. (2018) studied this question. Aspirin was evaluated. The 28th Scientific Conference of the International Aspirin Foundation facilitated international discussion on aspirin's mechanisms of action and its utility in modern medicine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: